Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients. [PDF]
Sainz-Amo R +11 more
europepmc +1 more source
[The Hospitalized Patient with Severe Aortic Stenosis]. [PDF]
Britto FW.
europepmc +1 more source
[Arrhythmia as the first symptom of neonatal cardiac tumors: Case report]. [PDF]
Ramírez-Terán ÓA, Tomás-Alvarado E.
europepmc +1 more source
[Autoimmune Regulatory Gene (AIRE) and Development of Autoimmune Thyroiditis in Down Syndrome]. [PDF]
Moran-Espinosa MC +5 more
europepmc +1 more source
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis. [PDF]
Rodero-Romero A +22 more
europepmc +1 more source
Cognitive outcomes in multiple sclerosis are shaped by divergent functional connectivity trajectories. [PDF]
Martinez-Heras E +13 more
europepmc +1 more source
Ocrelizumab: El primer medicamento aprobado para el tratamiento de las formas remitenterecurrente y primaria progresiva de esclerosis múltiple [PDF]
Abril Comesaña, Sheila
core +1 more source
[Effect of occlusal splinting on pain and joint space in patients with temporomandibular disorders. a case series study]. [PDF]
Pares-Ballasco JG +5 more
europepmc +1 more source
[XLVI REUNIÓN ANUAL DE LA SOCIEDAD ANDALUZA DE NEUROLOGÍA]. [PDF]
europepmc +1 more source
[Core data set for real world data in multiple sclerosis: customization for latin america from a global task force recommendation]. [PDF]
Rojas JI +26 more
europepmc +1 more source

